This HTML5 document contains 134 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
rdfshttp://www.w3.org/2000/01/rdf-schema#
skoshttp://www.w3.org/2004/02/skos/core#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n8http://dx.doi.org/10.1038/
n9http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
n13https://scigraph.springernature.com/pub.10.1038/
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q44044770
rdf:type
wikibase:Item
schema:description
2004年学术文章 наукова стаття, опублікована в серпні 2004 videnskabelig artikel 2004年學術文章 আগস্ট ২০০৪-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ 2004年学术文章 artigo científico บทความทางวิทยาศาสตร์ scientific article published in August 2004 2004年学术文章 vitenskapelig artikkel scienca artikolo articol științific 2004 nî lūn-bûn artikull shkencor teaduslik artikkel სამეცნიერო სტატია artículu científicu espublizáu en 2004 artigo científico artikel ilmiah 2004年學術文章 2004年学术文章 научная статья vědecký článek scientific article published in August 2004 artykuł naukowy artículo científico publicado en 2004 article científic vitskapeleg artikkel vedecký článok научни чланак 2004年学术文章 מאמר מדעי naučni članak article scientifique мақолаи илмӣ tieteellinen artikkeli επιστημονικό άρθρο wetenschappelijk artikel article scientific 2004년 논문 artikulong pang-agham 2004年の論文 vetenskaplig artikel مقالة علمية نشرت في أغسطس 2004 научни чланак 2004年学术文章 articolo scientifico scientific article published in August 2004 bài báo khoa học գիտական հոդված հրատարակված 2004 թվականի օգոստոսին 2004年學術文章 tudományos cikk bilimsel makale artigo científico 2004年學術文章 wissenschaftlicher Artikel 2004年學術文章 научна статия
p:P577
wds:Q44044770-4E56B33B-B1E2-4781-9ECF-FB83ABBAE295
wdt:P577
2004-08-01T00:00:00Z
p:P407
wds:Q44044770-ABD22C05-E5C0-4045-BC8F-30F5EE4937AF
wdt:P407
wd:Q1860
p:P2888
wds:Q44044770-18D16E1E-4694-426C-BE92-4EA6D54B5BC9
wdt:P2888
n13:sj.bmt.1704562
p:P2860
wds:Q44044770-DA6B3A5E-631C-43A9-8A75-E6238C9E6A11 wds:Q44044770-F3748064-0B39-4323-AD53-DD323F48A339 wds:Q44044770-C435BD9F-3177-4ACC-BDB8-59CD89113691 wds:Q44044770-C7CE38CD-2C7E-4AFC-9B28-D35F19CAD048 wds:Q44044770-CB7A6CA7-AD20-45BA-850D-9F499657435C wds:Q44044770-CC610ED4-DF36-4353-98FD-5F5606979818 wds:Q44044770-59C05A9E-8368-41B1-ABC2-C37BE4A5594D wds:Q44044770-5D13A8D3-EDD1-40E9-B631-B51E4F8A173A wds:Q44044770-79128711-F75E-46E4-801D-0B393DE0B063 wds:Q44044770-8FA86825-3EC0-4A42-867F-C4A035CD8B64 wds:Q44044770-A9115566-54ED-4ACD-8A49-403023B7EB51 wds:Q44044770-23B33C27-AA13-46C0-A054-3EF750B8C337 wds:Q44044770-33BF5C29-12BE-4DCA-9956-C05BB268E5F5 wds:Q44044770-3A4A696C-EFC5-4473-9C8D-5F845CC8402B wds:Q44044770-5737EC9B-710D-4846-9605-AF75EE64F80F
wdt:P2860
wd:Q41924796 wd:Q54230489 wd:Q71123629 wd:Q44429171 wd:Q44208130 wd:Q61868354 wd:Q34195428 wd:Q71197377 wd:Q44265645 wd:Q71059756 wd:Q73883434 wd:Q33348702 wd:Q73181635 wd:Q57905040 wd:Q78025075
p:P2093
wds:Q44044770-467B87D6-5E3D-4C97-AAD1-5238BFDB2FF0 wds:Q44044770-08F57366-E477-43FF-8B71-CABD6F33FABA wds:Q44044770-A0D14B4D-82EE-4313-B575-FDE6D6446702 wds:Q44044770-DB9C621A-04B0-4670-8FB1-F17B8CE4C718
wdt:P2093
Delasalle K Handy B Weber D Alexanian R
rdfs:label
Clinical outcomes with intensive therapy for patients with primary resistant multiple myeloma Clinical outcomes with intensive therapy for patients with primary resistant multiple myeloma
skos:prefLabel
Clinical outcomes with intensive therapy for patients with primary resistant multiple myeloma Clinical outcomes with intensive therapy for patients with primary resistant multiple myeloma
schema:name
Clinical outcomes with intensive therapy for patients with primary resistant multiple myeloma Clinical outcomes with intensive therapy for patients with primary resistant multiple myeloma
p:P50
wds:Q44044770-EA8E40B2-7036-4268-9A18-AC2B07D70046 wds:Q44044770-498A594D-F001-4CFA-AFB1-B1D51D2FEA04
wdt:P50
wd:Q89187648 wd:Q66764444
p:P1476
wds:Q44044770-FC2E5DDC-F42D-4F12-B862-EADBCE6F7E58
wdt:P1476
Clinical outcomes with intensive therapy for patients with primary resistant multiple myeloma
p:P304
wds:Q44044770-D9AC34D2-2960-49DE-8037-B7713E08C304
wdt:P304
229-234
p:P31
wds:Q44044770-D412D559-E727-41F0-B28E-0600E72FFB79
wdt:P31
wd:Q13442814
p:P698
wds:Q44044770-C5BC587E-219B-4EB8-99F9-C85CE40272EA
wdtn:P698
n9:15170166
wdt:P698
15170166
p:P1433
wds:Q44044770-61C8D1B9-C7DE-4427-BB5C-999150B9D0E9
wdt:P1433
wd:Q4941523
p:P433
wds:Q44044770-46DC5015-CC35-4054-9044-4326659163D0
p:P478
wds:Q44044770-9B9362D7-E65B-4FAA-A7B3-5AD23B61A7AD
wdt:P433
3
wdt:P478
34
p:P356
wds:Q44044770-FA441BCE-BA9D-4079-8BA6-CCAF055CE0BC
wdtn:P356
n8:SJ.BMT.1704562
wdt:P356
10.1038/SJ.BMT.1704562
p:P5875
wds:Q44044770-1A17BEF9-A4AD-4C4E-82E2-68A99F7D35B9
wdt:P5875
8536867